| Nanostructured lipid carriers for oral bioavailability enhancement of exemestane: formulation design, in vitro, ex vivo, and in vivo studies A Singh, YR Neupane, B Mangla, K Kohli Journal of pharmaceutical sciences 108 (10), 3382-3395, 2019 | 97 | 2019 |
| Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials B Mangla, S Javed, MH Sultan, P Kumar, K Kohli, A Najmi, HA Alhazmi, ... Phytotherapy Research 35 (10), 5440-5458, 2021 | 69 | 2021 |
| PEGylated liposomes as an emerging therapeutic platform for oral nanomedicine in cancer therapy: In vitro and in vivo assessment A Singh, YR Neupane, S Shafi, B Mangla, K Kohli Journal of molecular liquids 303, 112649, 2020 | 57 | 2020 |
| Quercetin loaded silver nanoparticles in hydrogel matrices for diabetic wound healing R Badhwar, B Mangla, YR Neupane, K Khanna, H Popli Nanotechnology 32 (50), 505102, 2021 | 45 | 2021 |
| Graphene-based biosensors for disease theranostics: Development, applications, and recent advancements HA Alhazmi, W Ahsan, B Mangla, S Javed, MZ Hassan, M Asmari, ... Nanotechnology Reviews 11 (1), 96-116, 2021 | 43 | 2021 |
| Nanostructured lipid carrier potentiated oral delivery of raloxifene for breast cancer treatment NK Soni, LJ Sonali, A Singh, B Mangla, YR Neupane, K Kohli Nanotechnology 31 (47), 475101, 2020 | 41 | 2020 |
| Lipid-nanopotentiated combinatorial delivery of tamoxifen and sulforaphane: ex vivo, in vivo and toxicity studies B Mangla, YR Neupane, A Singh, P Kumar, S Shafi, K Kohli Nanomedicine 15 (26), 2563-2583, 2020 | 41 | 2020 |
| Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug … S Javed, B Mangla, Y Almoshari, MH Sultan, W Ahsan Nanotechnology Reviews 11 (1), 1744-1777, 2022 | 30 | 2022 |
| Combination of natural agent with synthetic drug for the breast cancer therapy B Mangla, K Kohli Int J Drug Dev Res 10 (10), 22-26, 2018 | 30 | 2018 |
| Tamoxifen and Sulphoraphane for the breast cancer management: A synergistic nanomedicine approach B Mangla, YR Neupane, A Singh, K Kohli Medical Hypotheses 132, 109379, 2019 | 25 | 2019 |
| Systematic development and validation of RP-HPLC method for simultaneous estimation of tamoxifen and sulphoraphane with specific application for nanolipidic formulations B Mangla, S Beg, O Alam, W Ahsan, A Haque, KS Patel, WH Almalki, ... Arabian Journal of Chemistry 13 (11), 7909-7920, 2020 | 24 | 2020 |
| Design-of-experiments (DoE)-assisted fabrication of quercetin-loaded nanoemulgel and its evaluation against human skin cancer cell lines A Chitkara, B Mangla, P Kumar, S Javed, W Ahsan, H Popli Pharmaceutics 14 (11), 2517, 2022 | 20 | 2022 |
| Gefitinib: an updated review of its role in the cancer management, its nanotechnological interventions, recent patents and clinical trials P Kumar, B Mangla, S Javed, W Ahsan, P Musyuni, A Ahsan, G Aggarwal Recent patents on anti-cancer drug discovery 18 (4), 448-469, 2023 | 19 | 2023 |
| Nanocarriers-assisted needle-free vaccine delivery through oral and intranasal transmucosal routes: A novel therapeutic conduit B Mangla, S Javed, MH Sultan, W Ahsan, G Aggarwal, K Kohli Frontiers in Pharmacology 12, 757761, 2022 | 18 | 2022 |
| Vicissitudes of liquid crystals for solubility enhancement of poorly soluble drugs A Shoaib, B Mangla, S Javed, MH Sultan, SS Alqahtani, F Shakeel Journal of Molecular Liquids 321, 114924, 2021 | 18 | 2021 |
| Development and validation of a high throughput bioanalytical UPLC-MS/MS method for simultaneous determination of tamoxifen and sulphoraphane in rat plasma: Application to an … B Mangla, O Alam, RA Rub, M Iqbal, A Singh, KS Patel, K Kohli Journal of Chromatography B 1152, 122260, 2020 | 14 | 2020 |
| Recent advancements in the diagnosis, prevention, and prospective drug therapy of COVID-19 W Ahsan, HA Alhazmi, KS Patel, B Mangla, M Al Bratty, S Javed, A Najmi, ... Frontiers in public health 8, 384, 2020 | 14 | 2020 |
| PEGylated nanoliposomes potentiated oral combination therapy for effective cancer treatment A Singh, YR Neupane, B Mangla, S Shafi, K Kohli Current Drug Delivery 17 (9), 728-735, 2020 | 13 | 2020 |
| Reassessment of therapeutic applications of carbon nanotubes: A majestic and futuristic drug carrier B Mangla, S Javed, K Kohli, A Ahsan, W Ahsan Critical Reviews™ in Therapeutic Drug Carrier Systems 37 (4), 2020 | 13 | 2020 |
| Formulation development, optimization by box-behnken design, and in vitro characterization of gefitinib phospholipid complex based nanoemulsion drug delivery system Mohit, P Kumar, P Solanki, B Mangla, G Aggarwal Journal of Pharmaceutical Innovation 18 (3), 952-964, 2023 | 12 | 2023 |
